Inhaled fluticasone propionate by Diskus in the treatment of asthma *: a comparison of the efficacy of the same nominal dose given either once or twice a day

Authors :: Purucker, Mary E.
Rosebraugh, Curtis J.
Zhou, Feng
Meyer, Robert J.
Source :: Chest. October 2003, Vol. 124 Issue 4, p1584, 10 p.
Publication Year :: 2003
Abstract: Study objective: In September 2000, the US Food and Drug Administration (FDA) approved the use of Flovent Diskus (FD) [fluticasone propionate; GlaxoSmithKline; Research Triangle Park, NC], which is an orally [...]

Subjects :: United States. Food and Drug Administration -- Reports -- Analysis
Propionates -- Physiological aspects -- Health aspects -- Reports -- Analysis -- Methods
Chest -- Diseases
Clinical trials -- Analysis -- Physiological aspects -- Health aspects -- Methods -- Reports
Diagnosis -- Analysis -- Methods -- Reports -- Health aspects -- Physiological aspects
Oral medication -- Health aspects -- Dosage and administration
Asthma -- Health aspects -- Care and treatment -- Diagnosis -- Prevention
Health
Diagnosis
Diseases
Care and treatment
Prevention
Physiological aspects
Analysis
Reports
Methods
Dosage and administration
Health aspects

Tools